Lucid Diagnostics Inc. (NasdaqCM: LUCD)
Health Care · Health Care Equipment & Supplies · US
$0.98
+1.64% today · -16.9% 1Y
Lucid Diagnostics Inc. (NasdaqCM: LUCD) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $184.13M and employs 82 people.
Over the last twelve months the share price has lost 16.9%, trading between 0.86 and 1.63.
Tweenvest scores Lucid Diagnostics Inc. across four factors: quality 22/100, value 59/100. Its strongest factor is value.
LUCD price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $184.13M
- Revenue (TTM)
- $5.45M
- P/E
- —
- EPS
- -0.46
- Dividend yield
- —
- Beta (5Y)
- 1.08
- 52-week high
- $1.63
- 52-week low
- $0.86
- Avg volume (3M)
- —
- Shares outstanding
- 190.95M
- Employees
- 82
- Next earnings
- —
About Lucid Diagnostics Inc.
Lucid Diagnostics Inc. is a commercial-stage medical technology firm focused on diagnostic solutions. The company's primary objective is to serve patients afflicted with gastroesophageal reflux disease (GERD), commonly referred to as chronic heartburn or acid reflux, especially those at increased risk of developing precancerous esophageal conditions or the particularly aggressive esophageal adenocarcinoma. Their key product offerings include EsoGuard, an internally developed esophageal DNA test, and EsoCheck, a specialized device designed for collecting esophageal cells. Formed in 2018, Lucid Diagnostics Inc. has its headquarters in New York, New York, and operates as a subsidiary of PAVmed Inc.
- ISIN
- US54948X1090
- Founded
- 2018
- Listed since
- Oct 14, 2021
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $200.95B | $115.61 | -0.45% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $131.36B | $368.27 | -0.96% |
| Stryker CorporationNYSE: SYK | $126.81B | $332.15 | +0.47% |
| Medtronic plcNYSE: MDT | $116.66B | $91.72 | +0.64% |
| EssilorLuxottica Société anonymeENXTPA: EL | $85.36B | €160.50 | +0.85% |
| Boston Scientific CorporationNYSE: BSX | $72.26B | $47.43 | -4.87% |
| HOYA CorporationTSE: 7741 | $52.49B | ¥24,995.00 | +0.40% |
| Edwards Lifesciences CorporationNYSE: EW | $52.38B | $91.12 | +0.28% |
Figures last refreshed Aug 18, 2026.